Satoshi Tsuboi
Kobe Gakuin University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Satoshi Tsuboi.
Biochemical and Biophysical Research Communications | 1987
Naoki Teno; Satoshi Tsuboi; Norio Itoh; Hiroshi Okamoto; Yoshio Okada
The first studies on a series of the small synthetic thiol proteinase inhibitors, conservative common sequences in several thiol proteinase inhibitors, are described. Among the many interesting findings with synthetic thiol proteinase inhibitors was the observation that the most effective analogue, Z-Gln-Val-Val-Ala-Gly-OMe, whose amino and carboxyl groups were protected with Z and OMe, respectively, showed inhibitory activity on papain and cathepsin B and protected papain from egg cystatin, human low-molecular-weight kininogen and T-kininogen-induced inhibition but not from leupeptin-induced inhibition. Moreover, it was revealed that Z-Gln-Val-Val-OMe was the smallest peptide to exhibit a protective effect on papain.
Biochemical and Biophysical Research Communications | 1989
Yoshio Okada; Satoshi Tsuboi; Yuko Tsuda; Kazunori Nakabayashi; Yoko Nagamatsu; Junichiro Yamamoto
Various kinds of peptide fragments related to eglin c were prepared by the conventional solution method and their inhibitory effects on human leukocyte elastase, cathepsin G and alpha-chymotrypsin were examined. Peptide (31-40) inhibited cathepsin G (Ki = 2.3 x 10(-4) M), peptide (41-49) potently inhibited cathepsin G and alpha-chymotrypsin (Ki = 4.2 x 10(-5) M and 2.0 x 10(-5) M, respectively), and peptide (60-63) inhibited leukocyte elastase (Ki = 1.6 x 10(-4) M), whereas, peptide (31-35) weakly inhibited both elastase and cathepsin G (Ki = 2.1 x 10(-3) M and 7.3 x 10(-4) M, respectively).
FEBS Letters | 1990
Yoshio Okada; Satoshi Tsuboi; Yuko Tsuda; Yoko Nagamatsu; Junichiro Yamamoto
A trihexacontapeptide corresponding to the sequence 8–70 of eglin c and its related peptides were synthesized by the conventional solution method and their inhibitory activity against human leukocyte elastase, cathepsin G and α‐chymotrypsin was examined. Although synthetic eglin c (41–49) inhibited cathepsin G and α‐chymotrypsin (K i = 4.0 × 10−5 M and 2.0 × 10−5 M, respectively) but not leukocyte elastase, the synthetic trihexaconta‐peptide potently inhibited cathepsin G, α‐chymotrypsin and leukocyte elastase (K i = 1.8 × 10−9 M, 1.4 × 10−9 M and 2.2 × 10−9 M, respectively). The relationship between the stucture of eglin c and the inhibitory activity against the above enzymes is also described.
Biochemistry | 1992
Atsushi Yamamoto; Kouji Tomoo; Mitsunobu Doi; Hirofumi Ohishi; Masatoshi Inoue; Toshimasa Ishida; Daisuke Yamamoto; Satoshi Tsuboi; Hiroshi Okamoto; Yoshio Okada
Chemical & Pharmaceutical Bulletin | 1987
Luiz Juliano; Maria A. Juliano; Antonio Miranda; Satoshi Tsuboi; Yoshio Okada
International Journal of Peptide and Protein Research | 2009
Izaura Y. Hirata; Paulo Boschcov; Maria C. F. Oliveira; Maria A. Juliano; Antonio Miranda; Jair R. Chagas; Satoshi Tsuboi; Yoshio Okada; Luiz Juliano
International Journal of Peptide and Protein Research | 2009
Naoki Teno; Satoshi Tsuboi; Yoshio Okada; Norio Itoh; Hiroshi Okamoto
Journal of The Chemical Society-perkin Transactions 1 | 1991
Yoshio Okada; Satoshi Tsuboi
Chemical & Pharmaceutical Bulletin | 1990
Satoshi Tsuboi; Kazunori Nakabayashi; Yoshikazu Matsumoto; Naoki Teno; Yuko Tsuda; Yoshio Okada; Yoko Nagamatsu; Junichiro Yamamoto
Chemical & Pharmaceutical Bulletin | 1988
Yoshio Okada; Naoki Teno; Satoshi Tsuboi; Kazunori Nakabayashi; Norio Itoh; Hiroshi Okamoto; Norio Nishi